What the company does
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. It also provides Zegalogue, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon for treating congenital hyperinsulinism. In addition, the company developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical …
What the weekly tape is saying
ZEAL closed the latest completed week at 295.8 DKK. The 4-week return is -4.8% and the 12-week return is 2.9%. Trend Signal is inactive, Market Dynamics is 0.58. Setup signature: Deep recovery attempt with a 43/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 374.3 DKK
- Vs Trend Line
- -21.0%
- Fair Value
- 509.0 DKK
- Vs Fair Value
- -41.9%
- 52W High
- 556.0 DKK
- 52W Low
- 233.5 DKK
- Drawdown
- -46.8%
- Range Position
- 19.3%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 13
- 52W Active Breadth
- 25.0%
- Sector Scope
- DK Healthcare
- Sector Rank
- 21 of 21
- Sector Percentile
- 0.0%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
DK Healthcare
- Tracked Peers
- 21
- 4W Rank
- 17 of 21
- Avg 1W
- -0.6%
- Avg 4W
- 1.9%
- Trend Breadth
- 28.6%
- Positive MD
- 66.7%
DK Biotechnology
- Tracked Peers
- 7
- 4W Rank
- 5 of 7
- Avg 1W
- -0.5%
- Avg 4W
- -2.1%
- Trend Breadth
- 14.3%
- Positive RS
- 14.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.58
- 4W MD Change
- 1012.5%
- Relative Strength
- -26.15
- 4W RS Change
- -8.2%
- Expectation
- Undecided
- Probability
- 49.81%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 5.5M
- 13W Average
- 2.1M
- 52W Average
- 2.0M
- Vs 13W
- 2.7x
- Vs 52W
- 2.8x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 6.9%
- 52W Volatility
- 9.4%
- Upside Weeks
- 25
- Downside Weeks
- 27
- Downside Breadth
- 51.9%
- Avg Gain / Loss
- 6.6% / -6.8%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- CPH
- Country
- DK
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- DKK
- Market Cap
- 22.0B
Opportunity signals
- Market Dynamics is positive on the latest completed week.
- Volume is elevated versus the 13-week average, confirming attention.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- The share remains more than 20% below its 52-week high.
- The latest week was a sharp negative move.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 295.8 DKK | -9.3% | 374.3 DKK | 509.0 DKK | 0.58 | -26.15 | 5.5M | Off |
| 5 Jun 2026 | 326.3 DKK | 0.4% | 381.6 DKK | 508.9 DKK | 0.33 | -18.42 | 2.2M | Off |
| 29 May 2026 | 324.9 DKK | 2.2% | 384.9 DKK | 508.5 DKK | 0.31 | -20.59 | 1.8M | Off |
| 22 May 2026 | 318.0 DKK | 2.4% | 391.2 DKK | 508.1 DKK | 0.18 | -22.81 | 2.1M | Off |
| 15 May 2026 | 310.6 DKK | -9.0% | 396.1 DKK | 507.7 DKK | -0.06 | -24.17 | 1.6M | Off |
| 8 May 2026 | 341.2 DKK | 10.4% | 400.8 DKK | 507.4 DKK | -0.17 | -16.04 | 2.9M | Off |
| 1 May 2026 | 309.0 DKK | 1.9% | 406.0 DKK | 506.9 DKK | -0.60 | -24.65 | 2.1M | Off |
| 24 Apr 2026 | 303.3 DKK | -7.9% | 412.8 DKK | 506.3 DKK | -0.90 | -25.87 | 1.3M | Off |
| 17 Apr 2026 | 329.3 DKK | 14.4% | 417.4 DKK | 505.9 DKK | -1.10 | -22.47 | 1.9M | Off |
| 10 Apr 2026 | 287.8 DKK | -3.4% | 422.0 DKK | 505.2 DKK | -1.32 | -31.52 | 1.3M | Off |
| 3 Apr 2026 | 298.0 DKK | 3.5% | 426.1 DKK | 504.8 DKK | -1.29 | -27.90 | 836.2K | Off |
| 27 Mar 2026 | 288.0 DKK | 0.1% | 431.1 DKK | 504.2 DKK | -1.18 | -27.87 | 1.2M | Off |
| 20 Mar 2026 | 287.6 DKK | 7.2% | 436.1 DKK | 503.8 DKK | -1.14 | -28.18 | 2.4M | Off |
| 13 Mar 2026 | 268.2 DKK | 14.2% | 440.4 DKK | 503.4 DKK | -1.08 | -35.54 | 3.2M | Off |